Fig. 1 · Structure
Documents & Downloads
Revatropate
Muscarinic Antagonist
Revatropate is a potent muscarinic antagonist primarily targeting M1 and M3 receptors with significantly greater inhibitory effects compared to the M2 subtype. This compound is valuable in the investigation of urge urinary incontinence and functional bowel disorders, facilitating research into the modulation of cholinergic signaling in these conditions.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 149926-91-0 |
| Applications | Muscarinic Antagonist |
| Formula | C19H27NO4S |
| Molecular Weight | 365.49 |
| Synonyms | UK-112166 |
| SMILES | O=C([C@](CO)(C1=CC=CC=C1)CC[S@@](C)=O)O[C@H]2CN3CCC2CC3 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.